Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates. - Wikidata - wikimedia - TriplyDB

Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.

Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.

http://www.wikidata.org/entity/Q34342995

about

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects Neuroimaging and drug taking in primates Application of cross-species PET imaging to assess neurotransmitter release in brain Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults Estimating neurotransmitter kinetics with ntPET: a simulation study of temporal precision and effects of biased data.Brain imaging in nonhuman primates: insights into drug addiction.Synthesis of two potential NK1-receptor ligands using [1-11C]ethyl iodide and [1-11C]propyl iodide and initial PET-imaging.Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.History of childhood adversity is positively associated with ventral striatal dopamine responses to amphetamine.Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.Relationship between impulsivity, prefrontal anticipatory activation, and striatal dopamine release during rewarded task performance.Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers.Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons.Ageing and the nigrostriatal dopaminergic system.Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans.What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?Dopamine in the history of the schizophrenic brain: recent contributions of brain-imaging studies.Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience Oxytocin gene polymorphisms influence human dopaminergic function in a sex-dependent manner.Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography The Role of Dopamine in Value-Based Attentional Orienting Imaging of striatal dopamine release elicited with NMDA antagonists: is there anything there to be seen?Assessment of neurotoxicity from potential medications for drug abuse: ibogaine testing and brain imaging.Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.Investigating the dopaminergic synapse in vivo. II. Molecular imaging studies in small laboratory animals.[123I]Iodobenzamide binding to the rat dopamine D2 receptor in competition with haloperidol and endogenous dopamine--an in vivo imaging study with a dedicated small animal SPECT.NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans.PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands.Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies.Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion.Striatal D2 receptor binding in sleep bruxism: a controlled study with iodine-123-iodobenzamide and single-photon-emission computed tomography.Endogenously released dopamine inhibits the binding of dopaminergic PET and SPECT ligands in superfused rat striatal slices.Linking dopaminergic reward signals to the development of attentional bias: A positron emission tomographic study.

P2860

Q22248075-0575F856-53F1-420F-A469-39B2A11D832A Q24631230-5DD1E330-A664-4836-B9E4-6D8219D5ED8C Q26865012-960DC8D7-AB24-4910-B38A-E9C39249AA6B Q27306943-D1414D0A-3FC7-4136-A53C-CD48B5938AF7 Q31137052-3E0C334F-B221-4C25-9C68-7D62AC53F45D Q31141730-C5806545-6022-4234-ABB2-C4B06097FE07 Q33292462-CFA629D5-DE60-4123-9149-640FE62E045A Q33383360-A7C06AB1-9F41-413F-BD15-D5FF97B91054 Q33580523-4AE5C1B7-B332-433E-9A20-13BC123593E7 Q33693354-32C5C572-528D-4BD2-A7D4-2CBBB2EEF1DD Q33833648-E1B620D8-7424-46C8-A3CA-1609E89DF439 Q33867444-C7135390-BD8C-4EA0-AFE2-5DFB2F023D0E Q33921841-3440E706-0FFF-4829-BBA8-E965CB3D4312 Q34060104-D134281F-4894-4273-8567-94AA82F726B7 Q34199610-AC71AF32-3463-4154-A3F3-2C5B1FF60846 Q34359201-F90EC09C-8900-4AB3-8267-9B42E0BBB41D Q34627373-98DE14C0-0725-4976-AEAC-B0B6DB87C5A9 Q34893965-AF4280FD-DDBB-4ABB-ABF9-ACAA18655F5C Q35195505-B151D3E3-0ECB-410C-8C71-F1AEEE0AA161 Q35236303-F4584F97-2CEA-4A72-A42A-1B9069AA8902 Q36050571-9B7588B9-7A3B-4091-B71A-36D0117D88D5 Q36054572-EB46C759-25CC-4D5B-8757-53E1EDEA1C88 Q36083950-4736F975-1CA9-46A5-A4A2-91F92AD051F3 Q36198578-A97DB3F8-80A7-419D-9D32-E9FEE67A8A3D Q36619896-6EAAB531-AF80-4E91-917C-9738A7A86EEC Q36860038-97F176C2-5EC9-477B-90BD-57BC4272D617 Q36873099-34F48F8E-1F80-43D4-AA68-5D73441ABD12 Q37069577-B10E5EEA-1BFE-4C12-AE90-87A4AA11CD80 Q37106126-053A8EC3-E09B-4C80-8B61-034D72B08584 Q40407313-040C1F4C-6F30-4922-997C-4560BF00C433 Q43825625-93DFF367-37C6-44E2-8E5E-4E8C8EEFC446 Q48219140-60A982D5-924B-436C-A84F-2835EB78867A Q48354185-77AE81F1-39AC-48B5-AF67-654F276DBB8A Q48466159-850ED806-8CBB-41BA-863C-7D3AB5D05F9F Q48623993-C7E91DD1-622C-4498-9BB1-AE0418C60D07 Q48738632-DFBFD14D-C076-481D-A8BC-225E192AE1D0 Q48895830-7EE6D704-39E1-49E8-89E3-06667B58E4FE Q49065832-93971ADD-7582-4548-9473-8F5CC1AD3E2B Q50435925-A995D4E9-9243-41AC-B970-22B4B0342A47

P2860

Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.

http://www.wikidata.org/entity/Q34342995

description

1992 nî lūn-bûn

@nan

1992 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի մարտին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Amphetamine-stimulated dopamin ...... receptor in nonhuman primates.

@ast

Amphetamine-stimulated dopamin ...... receptor in nonhuman primates.

@en

Amphetamine-stimulated dopamin ...... receptor in nonhuman primates.

@nl

type

label

Amphetamine-stimulated dopamin ...... receptor in nonhuman primates.

@ast

Amphetamine-stimulated dopamin ...... receptor in nonhuman primates.

@en

Amphetamine-stimulated dopamin ...... receptor in nonhuman primates.

@nl

prefLabel

Amphetamine-stimulated dopamin ...... receptor in nonhuman primates.

@ast

Amphetamine-stimulated dopamin ...... receptor in nonhuman primates.

@en

Amphetamine-stimulated dopamin ...... receptor in nonhuman primates.

@nl

P1433

Q34342995-BD3AE8E9-4675-4ABD-93DC-833BFA14EAB8

P1476

Q34342995-ACE7C60B-842B-4824-BDCD-B0FC19620B52

P2093

Q34342995-0D6F6F33-EBC8-453B-8576-67C14AB12096

Q34342995-196922D5-E358-43AB-B89E-7701798BD06F

Q34342995-2B11379D-3087-4589-A248-A81ADB8BD115

Q34342995-2F66D410-7533-4D1A-B80F-E7490C0F4D5D

Q34342995-4F8DF0C6-6A52-4441-AB92-E87EF1FF9F39

Q34342995-5BD80F1D-CEAC-4376-B20E-094D8B2398ED

Q34342995-74B1F26F-9DAE-425D-8D9C-FCB126087D90

Q34342995-C7CBFE72-432D-41FF-AB2E-8AD8545F7F32

Q34342995-F22A935C-1302-452D-B81B-D2804A8872ED

Q34342995-FE7E76E9-8447-4890-B7F8-68581D49423B

P2860

Q34342995-47C45BCB-524F-4E2F-A0E1-444E846A455F

Q34342995-BEBE1200-AED0-474F-A919-685036CFB818

Q34342995-D14E2BAF-E849-4FC0-BE5B-A85D40184CF2

P304

Q34342995-0A278FD7-361A-490A-ACC5-27D031909903

P31

Q34342995-11713D52-196F-4882-9C80-4601DE68FB03

P356

Q34342995-5C35E865-9303-493D-9EE0-6C99AD5EA5B6

P433

Q34342995-00E09990-BBD6-45E0-B04E-C43EB7FEBF6F

P478

Q34342995-F13FE18C-DB50-493D-A980-209BF16C7E46

P577

Q34342995-56DB8C9E-15CD-4B6A-8553-D8F7A0E6EA14

P5875

Q34342995-0BFD33DD-23F6-494D-862E-E31ECA56CB4D

P698

Q34342995-0E7417BA-089F-4940-A71A-52C4EB9F675B

P921

Q34342995-21e7b28e-2db6-49a7-a24f-c01de65a6487

P356

P1433

P1476

Amphetamine-stimulated dopamin ...... receptor in nonhuman primates.

@en

P2093

Baldwin RM

http://www.w3.org/2001/XMLSchema#string

Hoffer PB

http://www.w3.org/2001/XMLSchema#string

Innis RB

http://www.w3.org/2001/XMLSchema#string

Laruelle M

http://www.w3.org/2001/XMLSchema#string

Malison RT

http://www.w3.org/2001/XMLSchema#string

Seibyl JP

http://www.w3.org/2001/XMLSchema#string

Smith EO

http://www.w3.org/2001/XMLSchema#string

Sybirska EH

http://www.w3.org/2001/XMLSchema#string

Zoghbi SS

http://www.w3.org/2001/XMLSchema#string

al-Tikriti M

http://www.w3.org/2001/XMLSchema#string

P2860

Tardive dyskinesia: review and update.

Study of cerebral function with positron computed tomography.

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.

P304

177-184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SYN.890100302

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

1992-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21622401

http://www.w3.org/2001/XMLSchema#string

P698

1532675

http://www.w3.org/2001/XMLSchema#string

P921